Abortion Early Clinical Trial
Official title:
Medication Abortion With Autonomous Self-Assessment Project at Independent Abortion Clinics: A Demonstration Project
NCT number | NCT05781061 |
Other study ID # | 1059 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 16, 2023 |
Est. completion date | June 15, 2023 |
In this study, the investigators propose to conduct a parallel study to MA-ASAP (ClinicalTrials.gov Identifier: NCT05278780) at an independent clinic.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | June 15, 2023 |
Est. primary completion date | June 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Can speak and read English - Has an address in a state where the study clinicians are licensed to practice medicine and where the service is legal - Is old enough to consent to abortion and study participation without parental consent in the study state - Has reviewed the study website - Has had a positive pregnancy test - Has signed the study informed consent form (ICF), which will be included within the questionnaire - Is pregnant with a gestational age of =77 days from last menstrual period - Desires MA - Has no symptoms of or risk factors for ectopic pregnancy - Has no medical contraindications to MA, specifically: Hemorrhagic disorder or concurrent anticoagulant therapy Chronic adrenal failure Concurrent long-term systemic corticosteroid therapy Inherited porphyria Allergy to mifepristone or misoprostol, or other prostaglandin - Is not asked by the site to have a synchronous consultation with clinician OR facility-based tests such as ultrasound, laboratory tests, examination, etc. - Is comfortable obtaining the abortion pills without a pre-treatment ultrasound and without speaking by phone or video with the abortion provider. |
Country | Name | City | State |
---|---|---|---|
United States | All Families Healthcare | Whitefish | Montana |
Lead Sponsor | Collaborator |
---|---|
Gynuity Health Projects | All Families Healthcare |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of participant questions | The proportion of participants who have questions after completing the questionnaire and the types of questions that are asked. | 6 months | |
Primary | Proportion of participants that are followed through the study | The numbers and proportions of people who complete the questionnaire once initiated, are reached by study staff after submitting a completed questionnaire, and are ultimately followed through the study. | 6 months | |
Primary | Incidence of reported problems by site staff | Problems with the study process as reported by site staff | 6 months | |
Primary | Study site satisfaction (self-reported) | Interest on the part of study sites to continue to utilize this approach to MA provision after the study ends. | 6 months | |
Primary | Incidence of Treatment-Emergent Adverse Events | Proportion of treated participants with SAE related to the study | 6 months | |
Secondary | Efficacy of computer algorithm to determine MA eligibility | We will estimate the predictive value of this algorithm for selecting participants who were deemed eligible for MA or ultimately did receive treatment without a synchronous consultation or facility-based tests | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03989869 -
Very Early Medical Abortion
|
N/A | |
Active, not recruiting |
NCT03736681 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage
|
Phase 1 | |
Completed |
NCT03636451 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
|
Phase 3 | |
Recruiting |
NCT05182008 -
A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial
|
N/A | |
Completed |
NCT04432792 -
The California Home Abortion by Telehealth (CHAT) Study
|
||
Completed |
NCT03417362 -
Delivery of Audiovisual Information on Early Medical Abortion
|
N/A | |
Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
Recruiting |
NCT04458558 -
Improving Access to Abortion in the Republic of Georgia
|
Phase 4 | |
Active, not recruiting |
NCT05278780 -
Medication Abortion With Autonomous Self-Assessment Project
|
N/A | |
Completed |
NCT03320057 -
Medication Abortion Via Pharmacy Dispensing
|
Phase 4 | |
Not yet recruiting |
NCT05986357 -
The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion
|
||
Completed |
NCT03047551 -
Transabdominal and Transvaginal Sonography in Medical Abortion
|
N/A | |
Completed |
NCT03913104 -
Mail Order Mifepristone Study
|
Phase 4 | |
Terminated |
NCT04139382 -
Using Telemedicine to Improve Early Medical Abortion at Home
|
N/A | |
Recruiting |
NCT05147857 -
Mid Trimester Abortion Effectiveness by Dilapan s
|
N/A | |
Completed |
NCT02522078 -
Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion
|
Phase 4 | |
Completed |
NCT05635955 -
Remimazolam Versus Propofol for Painless Abortion
|
Phase 2 | |
Active, not recruiting |
NCT05342974 -
Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
|
Early Phase 1 | |
Completed |
NCT03900728 -
Auriculotherapy During Medication Abortion
|
N/A |